Phillip Securities Group
Please note that the Day Light Saving of Europe and US will be effective on April 1st and March 11th respectively. The trading hours for those relevant contracts will be 1 hour earlier. Any questions, please contact us at 22776677.For details, please visit our foreign futures website or contact us at 22776677.Moreover,the spread of USD/JPY is low as one pip.Please click here for details
 
  Phillip Investor Notes

08-01-2025(Wed) 07-01-2025(Tue) 06-01-2025(Mon) 03-01-2025(Fri) 02-01-2025(Thu)
Page : 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 |
Investor Notes - Phillip Securities (HK) Ltd
Past Investor Notes  
Phillip Home Send to Friends Free Subscription Give Comments ¤¤¤åª©
13 Jan, 2025 (Monday)



WUXI XDC(2268)
Analysis¡G
WuXi Biologics and Huahai Pharmaceutical jointly established the joint venture WuXi XDC in the field of antibody-drug conjugates (ADC) manufacturing. WuXi XDC provides comprehensive end-to-end CRDMO services for global biopharmaceutical companies and developers, enabling seamless integration from concept to commercial production. By leveraging a highly integrated ADC technology platform, the company accelerates and transforms the global ADC drug development process, offering an open, integrated conjugation pharmaceutical technology platform to customers, reducing R&D costs, and benefiting patients. Global ADC CDMO capacity remains tight, with WuXi XDC's business exhibiting high irreplaceability in the ADC CDMO field. While Lonza is a major competitor, the labor and other costs of European and American CDMOs are significantly higher than those in China. Japanese and Korean CDMOs are still in the early stages of entering the ADC field, posing less competitive pressure on WuXi XDC. In terms of mid-year performance, despite the impact of geopolitical factors, WuXi XDC's demand remains strong. In the first half of 2024, the company's revenue reached 1.67 billion RMB, a year-on-year increase of 67.6%. At the same time, the total order backlog amounted to approximately 842 million USD, representing a growth of around 45.5% from the end of 2023, with significant increases in the number of phase III and PPQ projects. Looking at the ADC industry, according to PharmCube, seven domestic and foreign ADCs are in the NDA stage, and it is expected that they will be successively approved for listing from the end of 2024 to 2025, driving CMO demand. Furthermore, the initiation and advancement of multiple global phase III clinical trials, such as Lurbinectedin and Trastuzumab Deruxtecan ADCs, will promote growth in late-stage clinical production demand.
Strategy¡G
Buy-in Price: $33.00, Target Price: $36.30, Cut Loss Price: $30.00



Baguio Green (1397.HK) - Delivered strong financial results in 1H2024

Baguio Green Group (¡§Baguio¡¨) a leading integrated environmental services provider in Hong Kong, demonstrated robust financial performance in the first half of 2024, driven by its core business resilience and successful government contracts. Operating in essential service sectors including cleaning, waste management and recycling, landscaping, and pest control, the Company maintained growth momentum despite a challenging macroeconomic environment.

For the six months ended June 30, 2024, Baguio reported revenue of HK$1.291 billion, a year-on-year increase of 16.6%, with profit for the period rising 18.5% to HK$25.8 million. While the gross profit margin declined slightly to 7.5% due to rising labor costs, the strong performance of its cleaning and waste management segments offset this pressure. Baguio remains well-positioned as a provider of essential services with limited exposure to economic cycles, benefiting from growing government initiatives in sustainability and recycling. With a solid financial foundation, diverse revenue streams, and a clear growth trajectory supported by environmental policies, we expect FY2025E-FY2026E EPS to be HK$12.6 cents and HK$14.5 cents respectively, with PT of HK$0.98, implies a FY2025E P/E of 7.8x (~3-yrs historical average). Our investment rating is ¡§Buy¡¨, with an optimistic outlook for its future performance.

Delivered strong financial results in 1H2024

During the first half of 2024, Baguio delivered strong financial results, supported by growth across its major business segments. Revenue increased by 16.6% yoy to HK$1.291 billion, underpinned by a 20.1% surge in cleaning services revenue, which contributed 80.2% of total revenue, reaching HK$1.035 billion. This solid growth reflects the Company's success in securing new government contracts and expanding its service coverage. Additionally, the waste management and recycling segment recorded a 7.4% increase in revenue to HK$147.3 million, with its gross margin improving significantly by 4.2 percentage points to 12.9%, driven by the maturity of the "Plastic Recycling Pilot Scheme" and the addition of new recycling points under government contracts.

Gross profit rose by 12.4% to HK$97.07 million, despite a slight decline in the overall gross margin from 7.8% to 7.5%, mainly due to higher labor costs in the cleaning segment. This impact was mitigated by the improved profitability of the waste management and pest control segments, highlighting Baguio's ability to balance risks through its diversified business portfolio.

On cost management, administrative expenses remained well-controlled, with their share of total revenue decreasing to 4.8%. The Company also exhibited a healthy financial position, with its current ratio improving from 1.2x at the end of 2023 to 1.3x as of June 30, 2024. Bank borrowings decreased significantly by 47.5% year-on-year, and cash and bank balances surged by 84.3% to HK$76.3 million, reflecting improved liquidity and reduced financial leverage.

Baguio operates in four core segments: cleaning, waste management and recycling, landscaping, and pest control. These services are closely tied to the daily lives of Hong Kong residents. Cleaning services, the largest revenue contributor, benefited from comprehensive government contracts covering seven districts and serving a population of approximately 2.8 million. This reinforces Baguio's market leadership in Hong Kong's environmental services sector.

The waste management and recycling segment saw strong growth, bolstered by government initiatives to enhance recycling infrastructure. Despite the temporary suspension of the municipal waste charging scheme, the government accelerated its investment in recycling facilities, such as smart food waste recycling machines and mobile collection points. This directly drove growth in Baguio's recycling business. As a key contractor under the government's "Plastic Recycling Pilot Scheme," the Company is well-positioned to benefit from the upcoming Producer Responsibility Scheme for Beverage Containers, which is expected to further drive recycling volumes.

In addition, green technology has emerged as a new growth driver for Baguio. The Company has introduced smart recycling systems that integrate IoT technology and real-time data analytics, improving operational efficiency while reducing carbon emissions, which is highly consistent with the Hong Kong government's smart city and "Zero Landfill" goals. Its biochar plant, which began trial operations during the period, utilizes pyrolysis technology to convert yard waste into high-quality biochar, and further explored a high value-added environmental protection business model.

Investment Thesis

Looking ahead, we expect Baguio to continue benefiting from the government's increased focus on environmental sustainability, including expanding the food waste recycling market and implementing the Producer Responsibility Scheme for Beverage Containers. According to 2022 data, Hong Kong generates approximately 3,330 tonnes of food waste daily, while current processing capacity stands at only 600 tonnes. This indicates enormous growth potential in the food waste recycling market. As a leader in Hong Kong's recycling industry, Baguio is well-positioned to capitalize on this opportunity, particularly with its smart food waste recycling machines already deployed across the city. Furthermore, the development of the Northern Metropolis is expected to create additional opportunities for Baguio's core services. The region is anticipated to provide 500,000 new housing units. These developments are likely to drive demand for cleaning and waste management services, providing sustained revenue growth for the Company. Financially, Baguio's contracts on hand as of June 30, 2024, reached HK$4.6 billion, with HK$1302 million scheduled for recognition by the end of 2024 and HK$3297 million to be recognised over the next two years. This strong pipeline ensures high revenue visibility in the near to medium term. We expect FY2025E-FY2026E EPS to be HK$12.6 cents and HK$14.5 cents respectively, with PT of HK$0.98, implies a FY2025E P/E of 7.8x (~3-yrs historical average). Our investment rating is ¡§Buy¡¨.

Risk factors

1) Market competition intensifies; 2) Soaring in operating cost; and 3) Unexpected slowdown in service demand.

Financial

Click Here for PDF format...




Recommendation on 13-1-2025
RecommendationBuy
Price on Recommendation Date$ 0.630
Suggested purchase priceN/A
Target Price$ 0.980
Writer Info
Eric Li
(Research Analyst)
Tel: (+852 2277 6516)
Email:
erichyli@phillip.com.hk

Local Index
       Index    Change   Change%

World Index
       Index    Change   Change%
  

A-H spread
Stock Code H share
Price
A share
Price
H share
discount


Oversea Research Reports


Investment Service Centre



Enquiry : 2277 6666 OR investornotes@phillip.com.hk
If you cannot read this e-mail in the proper format, please click here to view the web version.

Information contained herein is based on sources that Phillip Securities (Hong Kong) Limited and/or its affiliates ( the ¡§Group¡¨) believe to be accurate. The Group does not bear responsibility for any loss occasioned by reliance placed upon the contents hereof. The Group (or its employees) may have interests in relevant investment products. For details of different products¡¦ risks, please view the Risk Disclosures Statement on http://www.phillip.com.hk.

If you DO NOT wish to receive further marketing emails from us, please click HERE to opt-out.

ª©Åv©Ò¦³¡A ½¦L¥²¨s¡C

Copyright(C) 2025 Phillip Securities (HK) Ltd. All Rights Reserved.


Copyright © 2011 Phillip Securities Group. All Rights Reserved [ Risk Disclosures Statement ] [ Terms and Conditions ] [ Personal Data Policy ]